PARACAINE Drug Patent Profile
When do Paracaine patents expire, and what generic alternatives are available?
Paracaine is a drug marketed by Optopics and is included in one NDA.
The generic ingredient in PARACAINE is proparacaine hydrochloride. There is one drug master file entry for this compound. Ten suppliers are listed for this compound. Additional details are available on the proparacaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paracaine
A generic version of PARACAINE was approved as proparacaine hydrochloride by BAUSCH AND LOMB INC on September 29th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARACAINE?
- What are the global sales for PARACAINE?
- What is Average Wholesale Price for PARACAINE?
Summary for PARACAINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Patent Applications: | 964 |
| DailyMed Link: | PARACAINE at DailyMed |
US Patents and Regulatory Information for PARACAINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optopics | PARACAINE | proparacaine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 087681-001 | Aug 5, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
